Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)
Clinical trial NCT03690206 · COMPLETED
Trial details
- NCT number
- NCT03690206
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2022-07-26
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.